Company Filing History:
Years Active: 2013-2022
Title: Fiona Lorraine Scott: Innovator in Lupus Treatment
Introduction
Fiona Lorraine Scott is a prominent inventor based in San Diego, California. She has made significant contributions to the field of medical research, particularly in the treatment of systemic lupus erythematosus (SLE), commonly known as lupus. With a total of four patents to her name, her work focuses on innovative compounds and methods that aim to improve the lives of those affected by this challenging autoimmune disease.
Latest Patents
Among her latest patents is a groundbreaking method for treating lupus through the administration of a modulator of sphingosine-1-phosphate receptor subtype 1 (S1P1). This patent outlines the general structure of these S1P1 modulators and their potential applications in treating systemic lupus erythematosus. Another notable patent involves selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis. This work provides compounds that selectively modulate the S1P receptor subtype 1, along with methods for their chiral synthesis. These inventions are crucial for developing treatments for diseases where modulation of the sphingosine 1 phosphate receptor is medically indicated.
Career Highlights
Fiona has worked with several notable companies in the pharmaceutical industry, including Receptos, Inc. and Celgene International II Sàrl. Her experience in these organizations has allowed her to collaborate on innovative projects that push the boundaries of
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.